The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a]azepin-4-yl)methyl)-5-methyl-1,3,4-oxadiazole ID: ALA5287223
Max Phase: Preclinical
Molecular Formula: C22H18ClN5O
Molecular Weight: 403.87
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nnc(C[C@H]2C=C(c3ccc(Cl)cc3)c3ccccc3-n3c(C)nnc32)o1
Standard InChI: InChI=1S/C22H18ClN5O/c1-13-24-27-22-16(12-21-26-25-14(2)29-21)11-19(15-7-9-17(23)10-8-15)18-5-3-4-6-20(18)28(13)22/h3-11,16H,12H2,1-2H3/t16-/m1/s1
Standard InChI Key: AGYIAWHWIUZNSD-MRXNPFEDSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
-1.1996 1.2802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3919 0.4779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8842 -0.1717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0601 -0.1717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4607 0.4581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2829 1.2604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4567 1.6257 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1805 0.2445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7794 0.8121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5899 1.6107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8009 1.8500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -0.8856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8844 -1.5997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2960 -2.3111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1206 -2.3111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5321 -1.6015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1243 -0.8856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8589 1.8509 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3378 2.4421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4753 2.5812 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9207 3.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2570 0.2447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5328 -3.0250 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.4704 -0.5515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2396 -0.8467 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1965 -1.6696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4006 -1.8829 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9519 -1.1918 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7794 -2.2525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
5 4 1 0
6 5 1 0
7 6 1 0
1 7 1 0
2 8 1 0
9 8 2 0
10 9 1 0
11 10 2 0
1 11 1 0
12 3 1 0
13 12 2 0
14 13 1 0
15 14 2 0
16 15 1 0
12 17 1 0
17 16 2 0
6 18 2 0
7 19 1 0
19 20 2 0
20 18 1 0
19 21 1 0
5 22 1 1
15 23 1 0
22 24 1 0
25 24 1 0
25 26 1 0
26 27 2 0
27 28 1 0
28 24 2 0
26 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 403.87Molecular Weight (Monoisotopic): 403.1200AlogP: 4.69#Rotatable Bonds: 3Polar Surface Area: 69.63Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.99CX LogP: 2.62CX LogD: 2.62Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.50Np Likeness Score: -0.89
References 1. Akunuri R, Vadakattu M, Bujji S, Veerareddy V, Madhavi YV, Nanduri S.. (2021) Fused-azepinones: Emerging scaffolds of medicinal importance., 220 [PMID:33901899 ] [10.1016/j.ejmech.2021.113445 ]